rdf:type |
|
lifeskim:mentions |
umls-concept:C0007113,
umls-concept:C0017262,
umls-concept:C0030705,
umls-concept:C0032790,
umls-concept:C0165519,
umls-concept:C0185117,
umls-concept:C0332293,
umls-concept:C0441767,
umls-concept:C0677850,
umls-concept:C1514474,
umls-concept:C2911684
|
pubmed:issue |
1
|
pubmed:dateCreated |
2008-3-31
|
pubmed:abstractText |
The matrix-metalloproteinases (MMPs) are thought to be critically involved in tumor invasion and metastasis. This retrospective study was aimed both to examine the gelatinase expression status in patients with rectal cancer and to investigate their prognostic value on survival.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1537-453X
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
55-63
|
pubmed:meshHeading |
pubmed-meshheading:18376229-Adenocarcinoma,
pubmed-meshheading:18376229-Cell Differentiation,
pubmed-meshheading:18376229-Chemotherapy, Adjuvant,
pubmed-meshheading:18376229-Combined Modality Therapy,
pubmed-meshheading:18376229-Female,
pubmed-meshheading:18376229-Follow-Up Studies,
pubmed-meshheading:18376229-Humans,
pubmed-meshheading:18376229-Immunoenzyme Techniques,
pubmed-meshheading:18376229-Lymphatic Metastasis,
pubmed-meshheading:18376229-Male,
pubmed-meshheading:18376229-Matrix Metalloproteinase 2,
pubmed-meshheading:18376229-Matrix Metalloproteinase 9,
pubmed-meshheading:18376229-Middle Aged,
pubmed-meshheading:18376229-Neoplasm Staging,
pubmed-meshheading:18376229-Prognosis,
pubmed-meshheading:18376229-Radiotherapy, Adjuvant,
pubmed-meshheading:18376229-Rectal Neoplasms,
pubmed-meshheading:18376229-Retrospective Studies,
pubmed-meshheading:18376229-Survival Rate,
pubmed-meshheading:18376229-Tissue Inhibitor of Metalloproteinase-1,
pubmed-meshheading:18376229-Tissue Inhibitor of Metalloproteinase-2
|
pubmed:year |
2008
|
pubmed:articleTitle |
Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
|
pubmed:affiliation |
Radiation Oncology, Gazi University Faculty of Medicine, Ankara, Turkey. diclehan@yahoo.com
|
pubmed:publicationType |
Journal Article
|